Exposure to phototoxic NSAIDs and quinolones is associated with an increased risk of melanoma

European Journal of Clinical Pharmacology

Volumn 69, Issue 7, 2013, Pages 1437-1444

  Siiskonen, Satu J ^a   Koomen, Els R ^b   Visser, Loes E ^a   Herings, Ron M C ^c   Guchelaar, Henk Jan ^b   Stricker, Bruno H Ch ^a,d   Nijsten, Tamar E C ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c PHARMO INSTITUTE FOR DRUG OUTCOMES RESEARCH   (Netherlands)

^d Drug Safety Unit   (Netherlands)

Author keywords

Carcinogenicity; Melanoma; NSAIDs; Phototoxicity; Quinolone

Indexed keywords

ANTIDIABETIC AGENT; ANTIINFECTIVE AGENT; CARDIAC AGENT; DIURETIC AGENT; NEUROLEPTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADULT; ARTICLE; CANCER RISK; COHORT ANALYSIS; CONTROLLED STUDY; CUTANEOUS MELANOMA; DISEASE ASSOCIATION; DRUG EXPOSURE; DRUG SAFETY; DRUG USE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; POPULATION BASED CASE CONTROL STUDY; PRIMARY TUMOR; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CASE-CONTROL STUDIES; COHORT STUDIES; DATABASES, FACTUAL; DERMATITIS, PHOTOTOXIC; DRUG PRESCRIPTIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MELANOMA; MIDDLE AGED; NETHERLANDS; PROPIONATES; PROSPECTIVE STUDIES; QUINOLONES; REGISTRIES; RISK; SKIN; SKIN NEOPLASMS;

EID: 84879115038     PISSN: 00316970     EISSN: 14321041     Source Type: Journal    
DOI: 10.1007/s00228-013-1476-x     Document Type: Article

References (37)

1. Gould JW, Mercurio MG, Elmets CA (1995) Cutaneous photosensitivity diseases induced by exogenous agents. J Am Acad Dermatol 33:551-573
2. Kerr A, Ferguson J (2010) Photoallergic contact dermatitis. Photodermatol Photoimmunol Photomed 26:56-65
3. Stein KR, Scheinfeld NS (2007) Drug-induced photoallergic and phototoxic reactions. Expert Opin Drug Saf 6:431-443
4. Dubakiene R, Kupriene M (2006) Scientific problems of photosensitivity. Medicina (Kaunas) 42:619-624
5. Moore DE (2002) Drug-induced cutaneous photosensitivity: incidence, mechanism, prevention and management. Drug Saf 25:345-372
6. Onoue S, Kawamura K, Igarashi N et al (2008) Reactive oxygen species assay-based risk assessment of drug-induced phototoxicity: classification criteria and application to drug candidates. J Pharm Biomed Anal 47:967-972
7. Volkovova K, Bilanicova D, Bartonova A et al Associations between environmental factors and incidence of cutaneous melanoma. Review. Environ Health 11[Suppl 1]:S12
8. Baudouin CVC, Aries M, Charveron M, Gall Y (1998) In vitro investigations of phototoxicity and photogenotoxicity of phenothiazine derivatives. Toxicol Lett 95:41-41
9. Epstein JH (1978) Photocarcinogenesis: a review. Natl Cancer Inst Monogr 1978(50):13-25
10. Moore DE (1998) Mechanisms of photosensitization by phototoxic drugs. Mutat Res 422:165-173
11. Stern RS (1998) Photocarcinogenicity of drugs. Toxicol Lett 102-103:389-392
12. Nijsten TE, Stern RS (2003) The increased risk of skin cancer is persistent after discontinuation of psoralen + ultraviolet A: a cohort study. J Investig Dermatol 121:252-258
13. Stern RS (2001) The risk of melanoma in association with long-term exposure to PUVA. J Am Acad Dermatol 44:755-761
14. Stern RS (2007) Psoralen and ultraviolet a light therapy for psoriasis. N Engl J Med 357:682-690
15. Karagas MR, Stukel TA, Umland V et al (2007) Reported use of photosensitizing medications and basal cell and squamous cell carcinoma of the skin: results of a population-based case-control study. J Investig Dermatol 127:2901-2903
16. Jensen AO, Thomsen HF, Engebjerg MC et al (2008) Use of photosensitising diuretics and risk of skin cancer: a population-based case-control study. Br J Cancer 99:1522-1528
17. Kaae J, Boyd HA, Hansen AV et al (2010) Photosensitizing medication use and risk of skin cancer. Cancer Epidemiol Biomarkers Prev 19:2942-2949
18. Van Herk-Sukel MP, Van De Poll-Franse LV, Lemmens VE et al (2010) New opportunities for drug outcomes research in cancer patients: the linkage of the Eindhoven Cancer Registry and the PHARMO Record Linkage System. Eur J Cancer 46:395-404
19. Koomen ER, Joosse A, Herings RM et al (2007) Is statin use associated with a reduced incidence, a reduced Breslow thickness or delayed metastasis of melanoma of the skin? Eur J Cancer 43:2580-2589
20. World Health Organization (WHO) (2011) ATC-DDD index. WHO Collaborating Centre for Drug Statistics Methodology, Norwegian Institute of Public Health, Oslo
21. Jensen AO, Thomsen HF, Engebjerg MC et al (2009) Use of oral glucocorticoids and risk of skin cancer and non-Hodgkin's lymphoma: a population-based case-control study. Br J Cancer 100:200-205
22. Johnson BE, Gibbs NK, Ferguson J (1997) Quinolone antibiotic with potential to photosensitize skin tumorigenesis. J Photochem Photobiol 37:171-173
23. Kidd S, Meunier JR, Traynor NJ et al (2000) The phototumorigenic fluoroquinolone, lomefloxacin, photosensitises p53 accumulation and transcriptional activity in human skin cells. J Photochem Photobiol 58:26-31
24. Lawrence JW, Claire DC, Weissig V et al (1996) Delayed cytotoxicity and cleavage of mitochondrial DNA in ciprofloxacin-treated mammalian cells. Mol Pharmacol 50:1178-1188
25. Ferguson J (2002) Photosensitivity due to drugs. Photodermatol Photoimmunol Photomed 18:262-269
26. Urbach F (1997) Phototoxicity and possible enhancement of photocarcinogenesis by fluorinated quinolone antibiotics. J Photochem Photobiol 37:169-170
27. Hamanaka H, Mizutani H, Asahig K et al (1999) Melanocyte melanin augments sparfloxacin-induced phototoxicity. J Dermatol Sci 21:27-33
28. Joosse A, Koomen ER, Casparie MK et al (2009) Non-steroidal anti-inflammatory drugs and melanoma risk: large Dutch population-based case-control study. J Investig Dermatol 129:2620-2627
29. Curiel-Lewandrowski C, Nijsten T, Gomez ML et al (2011) Long-term use of nonsteroidal anti-inflammatory drugs decreases the risk of cutaneous melanoma: results of a United States case-control study. J Investig Dermatol 131:1460-1468
30. Asgari MM, Maruti SS, White E (2008) A large cohort study of nonsteroidal anti-inflammatory drug use and melanoma incidence. J Natl Cancer Inst 100:967-971
31. Ming ME (2011) The search for a chemoprevention agent effective against melanoma: considerations and challenges. J Investig Dermatol 131:1401-1403
32. Jeter JM, Han J, Martinez ME et al (2012) Non-steroidal anti-inflammatory drugs, acetaminophen, and risk of skin cancer in the Nurses' Health Study. Cancer Causes Control 23:1451-1461
33. Ljunggren B (1985) Propionic acid-derived non-steroidal antiinflammatory drugs are phototoxic in vitro. Photodermatol 2:3-9
34. Kasparian NA, Mcloone JK, Meiser B (2009) Skin cancer-related prevention and screening behaviors: a review of the literature. J Behav Med 32:406-428
35. Allen JE (1993) Drug-induced photosensitivity. Clin Pharm 12:580-587
36. Lankerani L, Baron ED (2004) Photosensitivity to exogenous agents. J Cutan Med Surg 8:424-431
37. Bosca F, Marin ML, Miranda MA (2001) Photoreactivity of the nonsteroidal anti-inflammatory 2-arylpropionic acids with photosensitizing side effects. Photochem Photobiol 74:637-655